Smart bike could help Parkinson's patients exercise from home
NCT ID NCT05298150
First seen Jun 25, 2026 · Last updated Jul 08, 2026 · Updated 3 times
Summary
This study tests a smart exercise bike that adjusts its resistance based on how well a person performs, aiming to improve movement and thinking in people with Parkinson's disease. The bike is used at home and monitored remotely, so patients don't need to travel to a clinic. Researchers will track changes in abnormal movements and cognitive scores over six months in 72 participants.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dynamic cycling (smart exercise bike that adapts to performance)
- What this could lead to
- If it works, this could provide a convenient, home-based exercise therapy to ease movement problems and thinking issues in Parkinson's disease.
- What could go wrong
- This is a small, early-stage study with only 72 participants, so results may not apply to everyone. The intervention is exercise-based, so benefits may be modest and not a substitute for medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Apr 2022
- Finished
-
Apr 2026
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Diagnosis of PD using the UK Brain Bank criteria * Ability to perform informed consent. * Hoehn and Yahr (H\&Y) stages I-III when off medication, * Stable medical regimen of antiparkinsonian medication for at least six months Exclusion Criteria: * Montreal Cognitive Assessment Scoreless than 18 * Hamilton depression score of 20 or higher * Hamilton anxiety rating score greater than 24 * Clinical diagnosis including perinatal brain injury, stroke, and atypical parkinsonism * One or more signs or symptoms of untreated cardiovascular disease including Pain, discomfort in the chest, neck, jaw, arms or other areas that may result from ischemia - Shortness of breath at rest or with mild exertion - Dizziness or syncope - Orthopnea or paroxysmal nocturnal dyspnea - Ankle edema - Palpitations or tachycardia - Intermittent claudication - heart murmur - Unusual fatigue or shortness of breath with usual activity (ACSM Cardiovascular Risk Assessment)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Parkinson's disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Louis Stokes VA Medical Center, Cleveland, OH
Cleveland, Ohio, 44106-1702, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Walking memory tests may reveal early Parkinson's clues
- Colon tissue may hold clues to telling Parkinson's apart from Look-Alike diseases
- A genetic roadmap for Parkinson's: testing thousands to unlock clues
- Can gentle touch therapy calm Parkinson's tremors?
- Stem cell infusions aim to slow Parkinson's progression
- Can an inhaled levodopa ease Parkinson's OFF episodes? a study asks patients.